Table 6.
Pooled prevalence of TB within population groups and across study covariates within minority indigenous populations
| Studies (n) | Pooledα Prevalence TB (95% CI) | |
|---|---|---|
| Study Population | ||
| Minority indigenous populations | 24 | 2.27 (1.69, 2.92) |
| Comparative Studies | ||
| Non ‘minority indigenous’ populations | 4 | 4.96 (0.32, 14.23) |
| Minority indigenous populations | 4 | 5.04 (1.72, 9.93) |
| Analysis on indigenous populations only | ||
| WHO regions | ||
| SEAR | 18 | 2.23 (1.61, 2.95) |
| WPR | 6 | 2.31 (0.65, 4.91) |
| WHO Mortality Strata | ||
| A | 2 | 1.93 (1.65, 2.23) |
| B | 4 | 2.77 (0.08, 8.78) |
| D | 18 | 2.23 (1.61, 2.95) |
| Countries | ||
| Australia | 2 | 1.93 (1.65, 2.23) |
| India | 18 | 2.23 (1.61, 2.95) |
| Malaysia | 3 | 2.87 (0.00, 11.99) |
| Solomon Islands | 1 | 2.47 (1.62, 3.75) |
| Year of data collection | ||
| 1945–1970 | 4 | 2.46 (0.46, 5.95) |
| 1971–1995 | 4 | 1.44 (0.81, 2.24) |
| 1996–2020 | 16 | 2.44 (1.72, 3.28) |
|
Age <15 years ≥15 years |
1 15 |
13.64 (7.34, 23.93) 2.40 (1.55, 3.41) |
|
Sex Female Male |
9 | 1.01 (0.53, 1.63) 2.89 (1.56, 4.59) |
| Diagnostic methods | ||
| Clinical | 7 | 2.05 (1.34, 2.89) |
| Culture | 12 | 2.08 (1.28, 3.08) |
| Smear | 8 | 2.18 (1.34, 3.22) |
| Screening Method | ||
| Chest symptoms | 16 | 1.76 (1.2, 2.41) |
| Mantoux skin test | 2 | 1.93 (1.65, 2.23) |
| No pre-screening | 4 | 6.86 (1.37, 15.91) |
| X-ray | 2 | 0.37 (0.33, 0.42) |
Note: α Prevalence pooled when >1 data set, otherwise result is presented from a single study